The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Humulin M3 KwikPen (mixture 3) 100 IU/ml Suspension for Injection

100 international unit(s)/millilitre Suspension for injection

Eli Lilly Nederland B.V.PA2276/006/002

Main Information

Trade NameHumulin M3 KwikPen (mixture 3) 100 IU/ml Suspension for Injection
Active SubstancesHuman insulin (recombinant dna origin)
Strength100 international unit(s)/millilitre
Dosage FormSuspension for injection
Licence HolderEli Lilly Nederland B.V.
Licence NumberPA2276/006/002

Group Information

ATC CodeA10AD Insulins and analogues for injection, intermediate- or long-acting combined with fast-acting
A10AD01 insulin (human)


Licence Issued13/03/2015
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back